SFI
HRMY icon

Susquehanna Fundamental Investments’s Harmony Biosciences HRMY Stock Holding History

Susquehanna Fundamental Investments’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,497
Closed -$382K – 858
2025
Q1 		$382K Hold
11,497
– – 0.01% 909
2024
Q4 		$396K Buy
+11,497
New +$395K 0.01% 897
2024
Q2 		$465K Buy
+15,400
New +$463K 0.01% 707
2023
Q2 		– Sell
-13,094
Closed -$428K – 753
2023
Q1 		$428K Sell
13,094
-23,058
-64% -$1.05M 0.01% 718
2022
Q4 		$1.99M Sell
36,152
-5,398
-13% -$297K 0.03% 481
2022
Q3 		$1.84M Buy
+41,550
New +$2.03M 0.03% 611

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna Fundamental Investments's HRMY Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of Harmony Biosciences (HRMY) in Q2 2025, closing a stake of 11,497 shares — an estimated $382K sold.

Susquehanna Fundamental Investments first reported a position in HRMY in Q3 2022 and held it in 6 quarters. The position peaked at $1.99M in Q4 2022. 279 funds tracked by Wall St. Rank hold HRMY as of Q2 2025.

  • Susquehanna Fundamental Investments reported no remaining Harmony Biosciences position as of Q2 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 11,497 Harmony Biosciences shares in Q2 2025, an estimated $382K.
  • Susquehanna Fundamental Investments first reported a position in Harmony Biosciences in Q3 2022 and held it in 6 quarters.
  • Susquehanna Fundamental Investments's Harmony Biosciences position peaked at $1.99M in Q4 2022.
  • 279 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.